Previous Article | Next Article ![]()
Infection and Immunity, November 1998, p. 5286-5294, Vol. 66, No. 11
Division of Basic Traumatology,
Received 22 December 1997/Returned for modification 1 May
1998/Accepted 21 July 1998
Gamma interferon (IFN- Recent reports indicate that livers
of adult mice and humans contain not only a large population of NK
cells but also many T cells with NK-cell markers (12, 24, 29, 30,
34). In addition, livers of adult mice contain c-kit+
pluripotent stem cells (35, 40) that give rise to
multilineage cells, indicating that adult liver is still an important
hematopoietic and immunocompetent organ. It has been recently
demonstrated in mice that lipopolysaccharide (LPS) (endotoxin)
activates liver NK cells and NK1.1+ T cells via
interleukin-12 (IL-12) production from Kupffer cells (33).
IL-12 and gamma interferon (IFN- Several researchers examined cytokine production in mice subjected to
cecum ligation and puncture (CLP mice) because CLP mice can be a model
of severe bacterial infection and bacterial peritonitis (2, 6,
38). IFN- Mice.
Male BALB/c mice, BALB/c nu/nu mice, and C57BL/6 (B6)
mice 6 to 8 weeks of age were purchased from Japan SLC Inc., Hamamatsu, Japan. Mice were fed under specific-pathogen-free conditions.
CLP and CLC procedures.
CLP was performed essentially as
previously described (2). Briefly, after intraperitoneal
pentobarbital anesthetization, the anterior abdominal walls of the mice
were shaved and a small incision was made to expose the cecum, which
was ligated at its base with 3.0 silk. The cecum was punctured through
once with an 18-gauge needle, and a small volume of feces was placed on the exterior. In some experiments, the CLP was made with a 22-gauge needle. The cecum was then returned to the peritoneal cavity, and the
abdomen was closed (CLP procedure). Sham-operated mice underwent the
same procedure without ligation and puncture of the cecum. In other
experiments (cecal ligation and cut [CLC] procedure), after ligation
of the cecum at its base, the cecum was cut and resected at the end.
This procedure produced a more severe peritonitis in the mice.
Isolation of MNC.
Under ether anesthesia, mice were bled
from the subclavian artery and vein to obtain sera. The livers were
removed from the mice. Hepatic mononuclear cells (MNC) were prepared
essentially as previously described (33). Briefly, the liver
was passed through stainless steel mesh and suspended in Hanks balanced
salt solution. After one washing, liver MNC were isolated from
hepatocytes, nuclei of hepatocytes, and Kupffer cells with an
osmolarity- and pH-adjusted 33% Percoll solution (Sigma, St. Louis,
Mo.) containing 100 U of heparin per ml (centrifuged at 500 × g for 15 min at room temperature). The pellet was
resuspended in erythrocyte lysis solution (0.17 mM NH4Cl,
0.01 mM EDTA, 0.1 M Tris, pH 7.3) and then washed twice in 10% fetal
calf serum (FCS)-RPMI 1640 medium. The spleen was pressed through a
stainless steel mesh, and MNC were obtained after lysing of
erythrocytes. Peripheral blood MNC were obtained from heparinized blood
by Ficol-Hypaque density gradient centrifugation. MNC (2.5 × 106) were incubated for 18 h in 1 ml of 10% FCS-RPMI
(penicillin and streptomycin included) for 18 h in 24-well
flat-bottomed plates, and supernatants were subjected to enzyme-linked
immunosorbent assay (ELISA).
Collection of PLF.
To examine cytokine production by PEC, 2 ml of phosphate-buffered saline (PBS) was intraperitoneally injected
into CLP mice, a small incision was made in the abdominal wall, and
peritoneal lavage fluid (PLF) was collected with a syringe. After
centrifugation, supernatants of PLF were pooled for ELISA.
Isolation of plastic-adherent PEC and nonadherent PEC.
PLF
was obtained by injection of 2 ml of 10% FCS-RPMI 1640 after CLP and
passed through nylon mesh. PLF was then incubated in a 24-well
flat-bottomed plate for 2 h at 37°C in 5% CO2.
After gentle pipetting to collect nonadherent cells, adherent cells and
nonadherent cells were subjected to culture for 8 h and culture supernatants were subjected to ELISA.
Isolation of Kupffer cells.
The liver was minced, treated
with 5 ml of Dispase (1,000 U/ml) for 2 h at 37°C, and washed
twice in PBS. Hepatocytes were partly removed by centrifugation at 500 rpm (125 × g) for 5 min. After lysing of erythrocytes,
hepatic MNC were suspended in 10 ml of 10% FCS-RPMI 1640 and
incubated in collagen-coated plastic dishes (Falcon) for 2 h at
37°C in 5% CO2, and then nonadherent cells were gently
removed and adherent Kupffer cells were obtained with a cell scraper.
In vivo cell depletion.
Monoclonal mouse anti-NK1.1 antibody
(Ab) (PK136) (200 µg/mouse) or polyclonal rabbit anti-asialo GM1
(anti-AGM1) Ab (50 µg/mouse) was injected into B6 mice twice a week
before CLP in order to eliminate NK-type cells (37).
Polyclonal rabbit anti-AGM1 Ab was purchased from Wako. The PK136
hybridoma was grown in our laboratory. Depletion of NK1.1+
T cells was confirmed not only by direct determination (37) but also by the deletion of V Assays for serum IFN- Statistical analysis.
Differences between groups were
analyzed by the Mann-Whitney U test. Differences were considered
significant if P was <0.05.
Liver MNC produce IFN-
0019-9567/98/$04.00+0
Copyright © 1998, American Society for Microbiology. All rights reserved.
Role of Liver NK Cells and Peritoneal Macrophages
in Gamma Interferon and Interleukin-10 Production in Experimental
Bacterial Peritonitis in Mice
![]()
ABSTRACT
Top
Abstract
Introduction
Materials & Methods
Results
Discussion
References
), tumor necrosis factor alpha (TNF-
),
and interleukin-10 (IL-10) production by liver, spleen, lung, peripheral blood mononuclear cells (MNC), and peritoneal exudate cells
(PEC) in experimental bacterial peritonitis was examined by cecum
ligation and puncture (CLP) (with an 18-gauge needle) of BALB/c mice.
MNC of organs were cultured for 18 h, and cytokine levels in
supernatants were examined. Cytokines contained in peritoneal lavage
fluid were regarded as those produced by PEC. Only liver MNC and PEC
produced substantial amounts of IFN-
, and PEC were the main source
of IL-10, especially 12 h after CLP. As reflected by the cytokine
production by liver MNC and PEC, serum IFN-
and IL-10 levels were
elevated after CLP. C57BL/6 (B6) mice and BALB/c nude mice showed a
similar pattern of cytokine production. TNF-
levels in culture
supernatants, peritoneal lavage fluid, and sera were not significantly
elevated compared to those of sham-operated mice. In vivo depletion of
NK cells of B6 mice with anti-asialo GM1 or anti-NK1.1 antibody greatly
decreased IFN-
levels in liver MNC culture supernatants and sera,
suggesting that liver NK cells are IFN-
producers. On the other
hand, plastic-adherent PEC macrophages are the major IL-10 producers.
Mice subjected to a cecum ligation and cut procedure (which have a more
severe peritonitis) showed much higher IFN-
and IL-10 levels than
those subjected to CLP, while mice subjected to CLP with a smaller
(22-gauge) needle showed low levels of these cytokines. These findings
show that liver NK cells and PEC macrophages are important for the
production of proinflammatory and anti-inflammatory cytokines in
bacterial peritonitis.
![]()
INTRODUCTION
Top
Abstract
Introduction
Materials & Methods
Results
Discussion
References
) produced by NK cells as well as
NK1.1+ T cells are responsible for inducing antitumor
cytotoxicity of these cells (12, 23, 33, 34). Further, the
liver is well known as an organ which produces C-reactive protein in
inflammations (13).
is a representative of the T helper type 1 (Th1)
cytokines produced by NK cells, conventional T cells, and
NK1.1+ T cells (1, 18, 23, 36). On the other
hand, IL-10 is one of the representatives of Th2 cytokines produced by
macrophages and T cells (5, 7, 8, 14, 19, 20). Th1 cytokines trigger an inflammatory immune response, and Th2 cytokines
counterregulate Th1 cytokines (5, 7, 19, 26) and inhibit
inflammation beyond the maximum phase into the recovery phase. However,
there has been no report in which the production of IFN-
and IL-10 in mice with bacterial peritonitis was systematically examined. The
present study is designed to clarify the organs and leukocyte populations responsible for the production of these cytokines in CLP
mice. We demonstrate that liver NK cells and macrophages from
peritoneal exudate cells (PEC) produce IFN-
and IL-10, respectively, and systemic levels of these cytokines are likely to reflect cytokine production from these cells, suggesting that these cells play a
role in modulating inflammation of bacterial peritonitis.
![]()
MATERIALS AND METHODS
Top
Abstract
Introduction
Materials & Methods
Results
Discussion
References
14 T-cell receptor mRNA (which is specific for NK1.1+ T cells [37]).
, tumor necrosis factor alpha (TNF-
),
and IL-10 levels.
Cytokine levels were evaluated by using the
cytokine-specific ELISA commercially available from Endogen, Inc.
(Boston, Mass.).
![]()
RESULTS
Top
Abstract
Introduction
Materials & Methods
Results
Discussion
References
, and PEC produce IL-10.
Liver MNC of
BALB/c mice, especially those from mice 12 h after CLP, produced a
large amount of IFN-
in vitro, while splenocytes did not (Fig.
1). Serum IFN-
levels in CLP mice also
reached a peak 12 h after CLP. PEC also produced a substantial
amount of IFN-
(Fig. 1). However, TNF-
levels had a tendency to
increase after CLP, but the increases were not statistically
significant compared to results for sham operations (Fig.
2). PEC produced a large amount of IL-10,
and liver MNC produced a small but significant amount of IL-10, while
spleen MNC did not produce a significant amount of IL-10 (Fig.
3). Serum IL-10 also greatly increased
(Fig. 3). Although serum IL-10 levels were still high 24 h after
CLP, the levels approached basal levels by 48 h after CLP (not
shown). These results were confirmed further with B6 mice. Data from
five B6 mice are shown in Fig. 4.

View larger version (26K):
[in a new window]
FIG. 1.
Time course of IFN-
production by MNC and PEC (PLF)
and levels of IFN-
in serum. Four to eight individual mice of each
group (at least two independent experiments) were examined at the
indicated time points. Data are means ± standard errors.

View larger version (23K):
[in a new window]
FIG. 2.
Time course of TNF-
production by MNC and levels of
TNF-
in serum. Four to eight individual mice of each group were
examined at the indicated time points. Data are means ± standard
errors.

View larger version (31K):
[in a new window]
FIG. 3.
Time course of IL-10 production by MNC and levels of
IL-10 in serum. Four to eight individual mice of each group were
examined at the indicated time points. Data are means ± standard
errors.

View larger version (13K):
[in a new window]
FIG. 4.
Cytokine production by MNC and serum cytokine levels for
B6 mice 12 h after CLP. Data are means and standard errors.
Nude mice also produce IFN-
and IL-10.
Liver MNC of athymic
BALB/c nude mice also produced IFN-
, and PEC produced IL-10 (Fig.
5), suggesting that thymus-derived T
cells are not the major IFN-
and IL-10 producers. However, in
contrast to the case for normal mice, serum IFN-
levels were elevated even in nude mice that had the sham operation and did not
significantly differ from those in CLP mice.
|
Serum IFN-
and IL-10 levels depend on the severity of
peritonitis.
We first compared CLP mice with CLC mice. Since some
CLC mice died within 12 h after CLC and most CLC mice died within
24 h, we compared the groups of mice at 6 h after CLP or CLC.
CLC mice showed significantly higher serum IFN-
and IL-10 levels than CLP mice (Fig. 6). Although IFN-
production by liver MNC of CLC mice was also higher than that by liver
MNC of CLP mice, IL-10 levels in PLF were not significantly different
between CLP mice and CLC mice (Fig. 6). Subsequently, we compared
cytokine production by CLP mice with the puncture made by an 18-gauge
needle with that by CLP mice with the puncture made by a 22-gauge
needle at 12 h after CLP. As expected, MNC of CLP mice with the
puncture made by a 22-gauge needle produce small amounts of cytokines
(Fig. 7).
|
|
Liver NK cells are responsible for IFN-
production, but NK-cell
depletion did not affect mouse mortality.
We recently reported
that anti-AGM1 Ab treatment of B6 mice in vivo depletes only liver NK
cells, while anti-NK1.1 Ab treatment depletes both liver NK cells and
NK1.1+ T cells with intermediate T-cell receptor
(37). Since NK1.1 can be detected in only some strains of
mice, such as B6 and B10 mice, and most other strains lack NK1.1
antigen (Ag) (no Ab is available to detect a counterpart of NK1.1 Ag),
we used B6 mice. Because both NK cells and NK1.1+ T cells
produce IFN-
by NK1.1 Ag cross-linking (1) and
NK1.1+ T cells produce a larger amount of IFN-
than do
NK cells by the stimulation of IL-12 (23), we tried to
determine which type of cells in the livers of CLP mice produce
IFN-
. The results showed that either anti-AGM1 Ab or anti-NK1.1 Ab
pretreatment of B6 CLP mice similarly decreased IFN-
levels in liver
MNC supernatants and sera (Fig. 8),
suggesting that liver NK cells but not NK1.1+ T cells are
the main IFN-
producers in this model. Together with the results for
nude mice (Fig. 4), this suggested that NK cells but neither
conventional T cells nor NK1.1+ T cells are the main
IFN-
producers. However, the survival rate of BALB/c CLP mice
depleted of NK cells by anti-AGM1 Ab treatment was not significantly
different from that of control BALB/c CLP mice; within 48 h, 6 of
22 CLP mice and 6 of 20 NK-cell-depleted CLP mice died. On the other
hand, six CLP mice with the puncture made by a 22-gauge needle were
monitored, and all were alive after 48 h.
|
Plastic-adherent PEC are producers of IL-10. Since PEC of CLP mice contain a large population of granulocytes and smaller populations of lymphocytes and macrophages (not shown), we examined which subset produces IL-10. At 5 h after CLP, PLF was obtained, both plastic-adherent PEC and nonadherent PEC were cultured for 8 h, and IL-10 levels in culture supernatants were examined. The results show that adherent PEC produce a larger amount of IL-10 than do nonadherent PEC (Fig. 9), indicating that PEC macrophages are a main population responsible for IL-10 production. In contrast, plastic-adherent liver MNC (Kupffer cells) did not produce IL-10 (not shown), suggesting that IL-10 in liver MNC culture supernatants was produced by T cells.
|
Peripheral blood MNC and lung MNC of CLP mice do not produce
significant amounts of cytokines.
Levels of cytokine production by
peripheral blood MNC and lung MNC were examined. Neither produced
significant amounts of IFN-
, TNF-
, or IL-10, although lung MNC
produced a small amount of IL-10 (Table
1).
|
| |
DISCUSSION |
|---|
|
|
|---|
In the present study, we demonstrated that liver NK cells produce
a Th1-type cytokine, IFN-
; that PEC macrophages produce a Th2-type
cytokine, IL-10; and that both play an important role in the cytokine
cascade of experimental bacterial peritonitis. In contrast,
splenocytes, lung MNC, and peripheral blood MNC did not produce
significant amounts of these cytokines. Although TNF-
production by
MNC of the organs tested had a tendency to increase after CLP, the
increases were not statistically significant compared to results for
control mice. The amounts of IFN-
and IL-10 correlate with the
severity of inflammation, whereas it was also found that reduction of
IFN-
production by NK-cell depletion resulted in an augmentation of
IL-10 production, suggesting that IFN-
and IL-10 cross-regulate each
other. However, NK-cell depletion did not significantly affect the
mortality of CLP mice.
NK cells produce IFN-
when stimulated with IL-12 (1, 18,
25) or IL-18 (IFN-
-inducing factor) (25), both of
which are produced by monocyte lineage cells stimulated with bacterial Ags or bacterial superantigens (25, 36). Thus, IFN-
is
important not only for antitumor immunity but also for antibacterial
immunity (36). However, IFN-
together with TNF-
is
also reportedly crucial for endotoxin-induced lethal shock syndrome,
known as the generalized Shwartzman reaction, suggesting that
uncontrolled exaggeration of this innate response sometimes causes
multiorgan failure or shock (23, 28, 36, 41). On the other
hand, IL-10 is reported to antagonize Th1 cytokines (including IFN-
) and counterregulate inflammation of bacterial infection (5, 7, 8,
14, 19, 20, 38). IL-10 is also reported to be important to
decrease lethality in mouse endotoxemia and bacterial infection
(including CLP), because exogenous and endogenous IL-10 increases
resistance in these mice (14, 19, 39).
Our results are consistent with a previous report that the severity of inflammation in CLP mice depends on the diameter of the needle used for CLP (39). Nevertheless, in contrast to our present results, that report demonstrated that the serum IL-10 concentration was greater in the group with the small-diameter cecal puncture than in those with intermediate- and large-diameter punctures (39). The reason for this discrepancy is unknown at present. However, it was reported that the elevation of serum IL-10 was associated with the development of sepsis in trauma patients (31), and we also recently found that patients with severe bacterial peritonitis with septic shock or multiorgan failure have higher levels of IL-10 than patients with less severe bacterial peritonitis (27).
Although IFN-
and IL-10 normally antagonize each other (5, 7,
19), our findings indicate that both Th1 and Th2 cytokines could
be produced simultaneously in acute inflammations. In addition, it
should be noted that although IL-10 is usually considered an anti-inflammatory cytokine in bacterial infections, a recent study showed that IL-10 enhanced macrophage colony-stimulating factor-induced growth and functions of macrophages, including phagocytosis and H2O2 production (11). These findings
suggest that IL-10 is protective against bacterial infection not only
because it is an anti-inflammatory cytokine but also because it can be
positively involved in inflammation. A possibility that the role of
IL-10 in bacterial infections or its interaction with proinflammatory
cytokines could be more complex than previously expected is also
raised.
Of interest is that IL-10 is produced mainly in situ by PEC
macrophages, whereas IFN-
is produced mainly by liver NK cells. Since we recently reported that mouse Kupffer cells produce IL-12 after
intraperitoneal LPS injection (33), bacterial peritonitis may induce production of IFN-
from liver NK cells by stimulating Kupffer cells. It was also recently reported that intravenous Escherichia coli injection induces elevation of serum IL-12,
IFN-
, and IL-10 in baboons (15). Since Kupffer cells do
not produce IL-10 in CLP mice, it seems likely that bacterial
stimulation differentially stimulates monocyte lineage cells, PEC
macrophages, and Kupffer cells. In an earlier study (38),
the failure to detect plasma IFN-
in CLP mice was probably a
function of the source of the ELISA kit.
Splenocytes and MNC of organs other than the liver do not produce the
cytokines tested. It is possible that bacterial Ags or components may
be preferentially brought to the liver, because approximately 70% of
monocyte lineage cells of mammals reside in the liver as Kupffer cells
(4, 9, 21). In fact, most bacteria that enter the
bloodstream are trapped by Kupffer cells and are thereby removed from
the blood (4, 9, 21). In addition, substantial amounts of
bacterial Ags, including LPS or peptidoglycan polysaccharides, are
continuously brought from the intestine to the liver (16, 17,
22). It was reported that LPS priming of lymphocytes or
leukocytes augments their response to subsequent bacterial stimulation
(17, 32). Thus, it is conceivable that liver MNC are already
presensitized and respond immediately and vigorously to bacterial
infection. Of course, we do not deny that splenocytes can produce
cytokines; it is known that splenocytes respond to mitogens and produce
cytokines, and splenocytes stimulated with LPS or bacterial
superantigens in vitro produce a substantial amount of IFN-
(10). These findings, however, suggest that in vitro
experiments sometimes do not reflect immunological events occurring in
vivo. We propose that liver is a peculiar organ which is prepared to
promptly trigger Th1 immune response. The production of C-reactive
protein from hepatocytes (13) in inflammation supports our
proposal.
We recently found that liver NK1.1+ T cells are more potent
IFN-
producers than NK cells after in vivo IL-12 stimulation
(23). However, the present results suggest that NK cells are
the main IFN-
producers in bacterial peritonitis, because both
anti-AGM1 Ab and anti-NK1.1 Ab similarly inhibit IFN-
production. It
is suggested that different Ags or factors may preferentially stimulate distinct lymphocyte populations in the liver to produce IFN-
. Our
results also revealed that conventional thymus-derived T cells are not
the main IFN-
producers in bacterial peritonitis.
Although liver NK cells seemed to be important to induce the Th1 immune
response in bacterial peritonitis, NK-cell depletion in CLP mice did
not significantly affect mouse mortality. This finding suggests that
cells other than NK cells (including macrophages and granulocytes) and
cytokines other than IFN-
are important for the first defense
against bacterial peritonitis, although NK-cell depletion could not
completely suppress serum IFN-
. However, it was reported that
IFN-
is important for mouse resistance to Listeria
infection (3), and it has been recently demonstrated by use
of IFN-
receptor-deficient mice that IFN-
is essential for the
protection of mice in an experimental peritonitis model similar to CLP
(42). Although results with gene-mutated mice should be
interpreted carefully, it seems likely that IFN-
has a protective
role in peritonitis. It is also possible that NK cells and their Th1
cytokines may generate bacterial Ag-specific Th1 T-cell clones and
produce more effective antibacterial immunity against rechallenge with
the same bacteria or bacterial Ags.
TNF-
was not elevated significantly in CLP and CLC mice. The
mortality of CLP mice was not affected by anti-TNF-
Ab
(6) or in TNF-
receptor-deficient mice (42).
Since it was also reported that IL-10 inhibits TNF-
production in
endotoxemia (8, 19), the possibility is raised that a large
amount of IL-10 in CLP or CLC mice may inhibit TNF-
production.
Liver MNC of CLP mice with the puncture made by a 22-gauge needle
produced only a small amount of IFN-
, probably because liver MNC do
not respond to more localized infections.
For nude mice, serum IFN-
levels in mice with sham operations were
not significantly different from those in CLP mice despite the fact
that IFN-
production by liver MNC showed a clear disparity. Although
the exact reason for this discrepancy is unclear, NK cells and
extrathymic T cells in organs other than the liver of thymus-deficient
mice may somehow be activated to compensate for the lack of
thymus-derived T cells and produce IFN-
even when stimulated by a
sham operation.
IL-10 levels in PLF were not significantly different for CLP mice and CLC mice. It can be speculated that a large amount of IL-10 produced by PEC macrophages of CLC mice may rapidly shift into circulation and that the dilution of the IL-10 in the peritoneal cavity by PBS in the process of obtaining PLF may mask the difference.
The present study identifies the source of increased IFN-
and IL-10
in mice with bacterial peritonitis.
| |
FOOTNOTES |
|---|
* Corresponding author. Mailing address: Division of Basic Traumatology, National Defense Medical College Research Institute, Namiki, Tokorozawa 359-8513, Japan. Phone: 81-429-95-1633. Fax: 81-429-91-1613. E-mail: btraums{at}ndmc.ac.jp.
Editor: J. R. McGhee
| |
REFERENCES |
|---|
|
|
|---|
| 1. |
Arase, H.,
N. Arase, and T. Saito.
1996.
Interferon production by natural killer (NK) cells and NK1.1+ T cells upon NKR-P1 cross-linking.
J. Exp. Med.
183:2391-2396 |
| 2. | Baker, C. C., I. H. Chaudry, H. O. Gaines, and A. E. Baue. 1983. Evaluation of factors affecting mortality rate after sepsis in a murine cecal ligation and puncture model. Surgery 94:331-335[Medline]. |
| 3. | Bancroft, G. J., R. D. Schreiber, and E. R. Unanue. 1991. A T-cell-independent pathway of macrophage activation, defined in the scid mouse. Immunol. Rev. 124:5-24[Medline]. |
| 4. | Benacerraf, B., M. M. Sebestyen, and S. Schlossman. 1959. A quantitative study of the kinetics of blood clearance of P32 labeled Escherichia coli and staphylococci by the reticuloendotherial system. J. Exp. Med. 110:27-48[Abstract]. |
| 5. |
De Waal Malefyt, R.,
J. Abrams,
B. Bennett,
C. Figdor, and J. E. de Vries.
1991.
IL-10 inhibits cytokine synthesis by human monocytes: an autoregulatory role of IL-10 produced by monocytes.
J. Exp. Med.
174:1209-1220 |
| 6. | Eskandari, M. K., G. Bolgos, C. Miller, D. T. Nguyen, L. E. DeForge, and D. G. Remick. 1992. Anti-tumor necrosis factor antibody therapy fails to prevent lethality after cecal ligation and puncture or endotoxemia. J. Immunol. 148:2724-2730[Abstract]. |
| 7. | Fiorentino, D. F., A. Zlotnik, T. R. Mosmann, M. Howard, and A. O'Garra. 1991. IL-10 inhibits cytokine production by activated macrophages. J. Immunol. 147:3815-3822[Abstract]. |
| 8. |
Gerard, C.,
C. Bruyns,
A. Marchant,
D. Abramowicz,
P. Vandenbeele,
A. Delvaux,
W. Fiers,
M. Goldman, and T. Velu.
1993.
Interleukin 10 reduces the release of tumor necrosis factor and prevents lethality in experimental endotoxemia.
J. Exp. Med.
177:547-550 |
| 9. | Gregory, S. H., L. K. Barczynski, and E. J. Wing. 1992. Effector function of hepatocytes and Kupffer cells in the resolution of systemic bacterial infection. J. Leukoc. Biol. 51:421-424[Abstract]. |
| 10. | Habu, Y., and S. Seki. Unpublished data. |
| 11. |
Hashimoto, S.,
M. Yamada,
K. Motoyoshi, and K. S. Akagawa.
1997.
Enhancement of macrophage colony-stimulating factor-induced growth and differentiation of human monocytes by interleukin-10.
Blood.
89:315-321 |
| 12. |
Hashimoto, W.,
K. Takeda,
R. Anzai,
K. Ogasawara,
H. Sakihara,
K. Sugiura,
S. Seki, and K. Kumagai.
1995.
Cytotoxic NK1.1 Ag+ ![]() T cells with intermediate TCR induced in the liver of mice by IL-12.
J. Immunol.
154:4333-4340[Abstract].
|
| 13. | Haubrich, W. S., F. Schaffner, and J. E. Berk. 1995. Bockus gastroenterology, vol. 3. , p. 1871. W. B. Sanders Co., Philadelphia, Pa. |
| 14. |
Howard, M.,
T. Muchamuel,
S. Andrade, and S. Menon.
1993.
Interleukin 10 protects mice from lethal endotoxemia.
J. Exp. Med.
177:1205-1208 |
| 15. |
Jansen, P. M.,
T. C. T. M. van der Pouw Kraan,
I. W. de Jong,
G. van Mierlo,
J. Wijdenes,
A. A. Chang,
L. A. Aarden,
F. B. Taylor Jr, and C. E. Hack.
1996.
Release of interleukin-12 in experimental Escherichia coli septic shock in baboons: relation to plasma levels of interleukin-10 and interferon- .
Blood
87:5144-5151 |
| 16. | Lichtman, S. N., J. Wang, J. H. Schwab, and J. J. Lemasters. 1994. Comparison of peptidoglycan-polysaccharide and lipopolysaccharide stimulation of Kupffer cells to produce tumor necrosis factor and interleukin-1. Hepatology 19:1013-1022[Medline]. |
| 17. |
Lichtman, S. N.,
J. Keku,
J. H. Schwab, and R. B. Sartor.
1991.
Evidence for peptidoglycan absorption in rats with experimental small bowel bacterial overgrowth.
Infect. Immun.
59:555-562 |
| 18. |
Ma, X.,
J. M. Chow,
G. Gri,
G. Garra,
F. Gerosa,
S. F. Wolf,
R. Dzialo, and G. Trincheri.
1996.
The interleukin 12 p40 gene promoter is primed by interferon in monocytic cells.
J. Exp. Med.
183:147-157 |
| 19. |
Marchant, A.,
C. Bruyns,
P. Vandenabeele,
M. Ducarme,
C. Gerard,
A. Delvaux,
D. de Groote,
D. Abramowicz,
T. Velu, and M. Goldman.
1994.
IL-10 controls IFN- and TNF production during experimental endotoxemia.
Eur. J. Immunol.
24:1167-1171[Medline].
|
| 20. | Moore, K. W., A. O'Garra, R. de Waal Malefyt, P. Vieira, and T. R. Mosmann. 1993. Interleukin-10. Annu. Rev. Immunol. 11:165-190[Medline]. |
| 21. |
Moulder, J. W.
1985.
Comparative biology of intracellular parasitism.
Microbiol. Rev.
49:298-337 |
| 22. | Nolan, J. P. 1989. Intestinal endotoxins as mediators of hepatic injury: an idea whose time has come again. Hepatology 10:887-891[Medline]. |
| 23. |
Ogasawara, K.,
K. Takeda,
W. Hashimoto,
K. Shirai,
R. Okuyama,
N. Yanai,
M. Obinata,
K. Kumagai,
H. Takada,
H. Hiraide, and S. Seki.
1996.
Involvement of NK1+ T cells and their IFN-g production in the generalized Shwartzman reaction.
J. Immunol.
160:3522-3527 |
| 24. | Ohteki, T., R. Okuyama, S. Seki, T. Abo, K. Sugiura, A. Kusumi, T. Ohmori, H. Watanabe, and K. Kumagai. 1992. Age-dependent increase of extrathymic T cells in the liver and their appearance in the periphery of older mice. J. Immunol. 149:1562-1570[Abstract]. |
| 25. |
Okamura, H.,
H. Tsutsui,
T. Komatsu,
M. Yutsudo,
A. Hakura,
T. Tanimoto,
K. Torigoe,
T. Okura,
Y. Nukada,
K. Hattori,
K. Akita,
M. Namba,
F. Tanabe,
K. Konishi,
S. Fukuda, and M. Kurimoto.
1995.
Cloning of a new cytokine that induces IFN- production by T cells.
Nature (London)
378:88-91[Medline].
|
| 26. | Okura, Y., T. Yamamoto, S. Goto, T. Inomata, S. Hirono, H. Hanawa, L. Feng, C. B. Wilson, I. Kihara, T. Izumi, A. Shibata, Y. Aizawa, S. Seki, and T. Abo. 1997. Characterization of cytokine and iNOS mRNA expression in situ during the course of experimental autoimmune myocarditis in rats. J. Mol. Cell. Cardiol. 29:491-502[Medline]. |
| 27. | Ono, S., S. Aosasa, S. Osada, and H. Mochizuki. Unpublished data. |
| 28. |
Ozman, L.,
M. Pericin,
J. Hakimi,
R. A. Chizzonite,
M. Wysocka,
G. Trinchieri,
M. Gately, and G. Garotta.
1994.
Interleukin 12, interferon , and tumor necrosis factor are the key cytokines of the generalized Shwartzman reaction.
J. Exp. Med.
180:907-916 |
| 29. |
Sato, K.,
K. Ohtsuka,
K. Hasegawa,
S. Yamagiwa,
H. Watanabe,
H. Asakura, and T. Abo.
1995.
Evidence for extrathymic generation of intermediate T cell receptor cells in the liver revealed in thymectomized, irradiated mice subjected to bone marrow transplantation.
J. Exp. Med.
182:759-767 |
| 30. |
Satoh, M.,
S. Seki,
W. Hashimoto,
K. Ogasawara,
T. Kobayashi,
K. Kumagai,
S. Matsuno, and K. Takeda.
1996.
Cytotoxic ![]() or ![]() T cells with a natural killer cell marker, CD56, induced from human peripheral blood lymphocytes by a combination of IL-12 and IL-2.
J. Immunol.
157:3886-3892[Abstract].
|
| 31. | Sherry, R. M., J. I. Cue, J. K. Goddard, J. B. Parramore, and J. T. DiPiro. 1996. Interleukin-10 is associated with the development of sepsis in trauma patients. J. Trauma 40:613-616[Medline]. |
| 32. | Smedly, L. A., M. G. Tonnesen, R. A. Sandhaus, C. Haslett, L. A. Guthrie, R. B. Johnston, Jr., P. M. Henson, and G. S. Worthen. 1986. Neutrophil-mediated injury to endothelial cells. Enhancement by endotoxin and essential role of neutrophil elastase. J. Clin. Invest. 77:1233-1243. |
| 33. |
Takahashi, M.,
K. Ogasawara,
K. Takeda,
W. Hashimoto,
H. Sakihara,
K. Kumagai,
R. Anzai,
M. Satoh, and S. Seki.
1996.
LPS induces NK1.1+ ![]() T cells with potent cytotoxicity in the liver of mice via production of IL-12 from Kupffer cells.
J. Immunol.
156:2436-2442[Abstract].
|
| 34. |
Takeda, K.,
S. Seki,
K. Ogasawara,
R. Anzai,
W. Hashimoto,
K. Sugiura,
M. Takahashi,
M. Satoh, and K. Kumagai.
1996.
Liver NK1.1+ CD4+ ![]() T cells activated by IL-12 as a major effector in inhibition of experimental tumor metastasis.
J. Immunol.
156:3366-3373[Abstract].
|
| 35. | Taniguchi, H., T. Toyoshima, K. Fukao, and H. Nakauchi. 1996. Presence of hematopoietic stem cells in the adult liver. Nat. Med. 2:198-204[Medline]. |
| 36. | Trinchieri, G. 1995. Interleukin-12: A proinflammatory cytokine with immunoregulatory functions that bridge innate resistance and antigen-specific adaptive immunity. Annu. Rev. Immunol. 13:251-276[Medline]. |
| 37. | Tsukahara, A., S. Seki, T. Iiai, T. Moroda, H. Watanabe, S. Suzuki, T. Tada, H. Hiraide, K. Hatakeyama, and T. Abo. 1997. Mouse liver T cells: their change with aging and in comparison with peripheral T cells. Hepatology 26:301-309[Medline]. |
| 38. | van der Poll, T., A. Marchant, W. A. Buurman, L. Berman, C. V. Keogh, D. D. Lazarus, L. Nguyen, M. Goldman, L. L. Moldawer, and S. F. Lowry. 1995. Endogenous IL-10 protects mice from death during septic peritonitis. J. Immunol. 155:5397-5401[Abstract]. |
| 39. | Walley, K. R., N. W. Lukas, T. J. Stanford, R. M. Strieter, and S. Kunkel. 1996. Balance of inflammatory cytokines related to severity and mortality of murine sepsis. Infect. Immun. 64:4733-4738[Abstract]. |
| 40. |
Watanabe, H.,
C. Miyaji,
S. Seki, and T. Abo.
1996.
c-kit+ stem cells and thymocyte precursors in the liver of adult mice.
J. Exp. Med.
184:687-693 |
| 41. |
Wysocka, M.,
M. Kubin,
L. Q. Vieria,
L. Ozman,
G. Garotta,
P. Scott, and G. Trinchieri.
1995.
Interleukin-12 is required for interferon- production and lethality in lipopolysaccharide-induced shock in mice.
Eur. J. Immunol.
25:672-676[Medline].
|
| 42. |
Zantl, N.,
A. Uebe,
B. Neumann,
H. Wagner,
J. R. Siewert,
B. Holzman,
C. D. Heidecke, and K. Pfeffer.
1998.
Essential role of gamma interferon in survival of colon ascendens stent peritonitis, a novel murine model of abdominal sepsis.
Infect. Immun.
66:2300-2309 |
This article has been cited by other articles:
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Copyright © 2009 by the American Society for Microbiology. For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»